Estradiol and Progesterone in Hospitalized COVID-19 Patients : Acute Estradiol and Progesterone Therapy in Hospitalized Adults to Reduce Coronavirus Disease (COVID-19) Severity: A Randomized Control Trial

The purpose of this study is to determine to what extent a short systemic steroid therapy with estradiol and progesterone, administered early to hospitalized and confirmed COVID-19 positive patients of both sexes in addition to standard of care (SOC) can reduce the severity of symptoms and outcomes compared to SOC alone..

Media Type:

Clinical Trial

Year of Publication:

2021

Publication:

2021

Contained In:

ClinicalTrials.gov - (2021) vom: 04. Mai To Main Record - year:2021

Language:

English

Links:

Volltext [Kostenfrei]

Keywords:

610
Medical Condition: Covid19
Phase: Phase 2
Recruitment Status: Not yet recruiting
Study Type: Interventional

Notes:

Source: Link to the current ClinicalTrials.gov record., First posted: April 29, 2021, Last downloaded: ClinicalTrials.gov processed this data on June 14, 2021, Last updated: June 15, 2021

NCTID:

04865029

Study Publications:

PPN (Catalogue-ID):

CTG003757048